Signos Launches New FDA-Cleared Glucose Monitoring System for Weight Management

Credit: Adobe Stock/InsideCreativeHouse

Signos, a metabolic health company, has unveiled a groundbreaking tool that could change the way millions of Americans approach weight management and overall health. The company’s new glucose monitoring system is the first ever U.S. Food and Drug Administration (FDA)-cleared, over-the-counter device designed to help people track how food, movement, sleep, stress and other lifestyle factors affect their bodies in real time.

At the center of this innovation is the integration of the Stelo by Dexcom glucose biosensor with Signos’ artificial intelligence (AI)-powered mobile platform. Together, these tools go beyond simply measuring glucose. They translate raw data into personalized insights and recommendations, helping people understand how their choices directly impact metabolism and health.

According to Signos CEO and founder Sharam Fouladgar-Mercer, this launch is about more than technology — it’s about giving individuals ownership of their health. “Everyone deserves access to insights that help them live healthier, longer, more vibrant lives,” he said. “This is more than a product launch — it’s a mission.”

The need for this type of tool is significant, as nearly three-quarters of U.S. adults have overweight or obesity, and 88% of Americans are considered metabolically unhealthy. With global diabetes cases expected to climb to 1.3 billion by 2050, Signos aims to provide a proactive solution that empowers individuals to take control before serious health complications arise.

Key benefits of the Signos System include the following:

• Personalized guidance: The platform interprets glucose fluctuations and provides practical, easy-to-follow suggestions.
• Holistic health tracking: Users can see how meals, exercise, sleep and stress all interact to influence metabolism.
• Accessibility: As an FDA-cleared, over-the-counter option, the system is available without prescriptions or complicated insurance requirements.
• Prevention-focused care: By understanding glucose patterns early, people can make lifestyle changes that may reduce the risk of obesity, diabetes and other chronic diseases.

Now available to the public, Signos offers a revolutionary new way to monitor glucose, personalize health insights and make meaningful lifestyle changes — all from the convenience of a smartphone.

Visit Signos.com for more information.